Terms: = Kidney tumors AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
94 results:
1. TTC13 expression and stat3 activation may form a positive feedback loop to promote ccRCC progression.
Xie L; Fang Y; Chen J; Meng W; Guan Y; Gong W
PeerJ; 2023; 11():e16316. PubMed ID: 37927783
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced synergy of pacritinib with temsirolimus and sunitinib in preclinical renal cell carcinoma model by targeting JAK2/STAT pathway.
Mao F; Gao L; Liu L; Tang Y
J Chemother; 2024 May; 36(3):238-248. PubMed ID: 37916436
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
4. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
5. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/stat3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
6. Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma.
Lin H; Fu L; Li P; Zhu J; Xu Q; Wang Y; Mumin MA; Zhou X; Chen Y; Shu G; Yao G; Chen M; Lu J; Zhang L; Liu Y; Zhao Y; Bao J; Chen W; Luo J; Li X; Chen Z; Cao J
J Transl Med; 2023 May; 21(1):343. PubMed ID: 37221577
[TBL] [Abstract] [Full Text] [Related]
7. The Feasibility and Value of a Focal Therapy Multidisciplinary Tumor Board, Including Radiographic and Pathological Overreads in Refining the Selection for High Intensity Focused Ultrasound in Prostate Cancer Patients.
Benidir T; Wood A; Lone Z; Schwen Z; Abouassaly R; Nguyen J; Olivares R; Weight CJ; Purysko AS
Urol Pract; 2023 Jul; 10(4):372-377. PubMed ID: 37103528
[TBL] [Abstract] [Full Text] [Related]
8. circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/stat3 pathway.
Shou Y; Yue C; Wang Q; Liu J; Xu J; Miao Q; Liu D; Yang H; Liu Y; Zhang X
Cell Death Dis; 2023 Mar; 14(3):232. PubMed ID: 37002206
[TBL] [Abstract] [Full Text] [Related]
9. Indoxyl Sulfate Promotes Metastatic Characteristics of Ovarian Cancer Cells via Aryl Hydrocarbon Receptor-Mediated Downregulation of the Mas Receptor.
Saito S; Koya Y; Kajiyama H; Yamashita M; Nawa A
Lab Invest; 2023 Mar; 103(3):100025. PubMed ID: 36925201
[TBL] [Abstract] [Full Text] [Related]
10. Sunitinib promotes apoptosis via p38 MAPK activation and stat3 downregulation in oral keratinocytes.
Fukada S; Ohta K; Sakuma M; Akagi M; Kato H; Naruse T; Nakagawa T; Shigeishi H; Nishi H; Takechi M; Aikawa T
Oral Dis; 2024 Mar; 30(2):639-649. PubMed ID: 36447393
[TBL] [Abstract] [Full Text] [Related]
11. An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.
Lu X; Vano Y; Helleux A; Su X; Lindner V; Davidson G; Mouawad R; Spano JP; Rouprêt M; Elaidi R; Compérat E; Verkarre V; Sun C; Chevreau C; Bennamoun M; Lang H; Tricard T; Cheng W; Xu L; Davidson I; Yan F; Fridman WH; Sautes-Fridman C; Oudard S; Malouf GG
Clin Cancer Res; 2023 Apr; 29(7):1279-1291. PubMed ID: 36374555
[TBL] [Abstract] [Full Text] [Related]
12. Tumor-associated macrophages promote migration and invasion via modulating IL-6/stat3 signaling in renal cell carcinoma.
Chen S; Qian S; Zhang L; Pan X; Qu F; Yu Y; Gu Z; Cui X; Shen H
Int Immunopharmacol; 2022 Oct; 111():109139. PubMed ID: 35964405
[TBL] [Abstract] [Full Text] [Related]
13. Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via stat3 pathway.
Zhang W; Zheng X; Yu Y; Zheng L; Lan J; Wu Y; Liu H; Zhao A; Huang H; Chen W
Int J Biol Sci; 2022; 18(8):3209-3222. PubMed ID: 35637970
[TBL] [Abstract] [Full Text] [Related]
14. Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment.
Li J; Cao P; Chen Y; Wang J; Sun X; Chen R; Wang G; Hou J
Exp Cell Res; 2022 Aug; 417(1):113197. PubMed ID: 35568074
[TBL] [Abstract] [Full Text] [Related]
15. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/stat3 feedback loop.
Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q
Cell Mol Biol Lett; 2022 May; 27(1):36. PubMed ID: 35562668
[TBL] [Abstract] [Full Text] [Related]
16. Effect of Curcumin on the Head and Neck Squamous Cell Carcinoma Cell Line HN5.
Abdolahinia ED; Ahmadian S; Bohlouli S; Gharehbagh FJ; Jahandizi NG; Vahed SZ; Saadat YR; Aghbali A; Sharifi S; Dizaj SM; Alsharif KF; Khan H
Curr Mol Pharmacol; 2023; 16(3):374-380. PubMed ID: 35431006
[TBL] [Abstract] [Full Text] [Related]
17. T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages.
Torres GM; Yang H; Park C; Spezza PA; Khatwani N; Bhandari R; Liby KT; Pioli PA
Front Immunol; 2022; 13():768753. PubMed ID: 35265066
[TBL] [Abstract] [Full Text] [Related]
18.
Yamamoto K; Ioroi T; Shinomiya K; Yoshida A; Harada K; Fujisawa M; Omura T; Ikemi Y; Nakagawa S; Yonezawa A; Ogawa O; Matsubara K; Iwamoto T; Nishikawa K; Hayashi S; Tohara D; Murakami Y; Motoshima T; Jono H; Yano I
Oncol Res; 2022 May; 29(1):11-23. PubMed ID: 35016744
[TBL] [Abstract] [Full Text] [Related]
19. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract] [Full Text] [Related]
20. OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma.
Liu W; Li H; Aerbajinai W; Botos I; Rodgers GP
Oncogene; 2022 Jan; 41(1):72-82. PubMed ID: 34675408
[TBL] [Abstract] [Full Text] [Related]
[Next]
